AARP to monitor Senate vote on Medicare Rx bargaining bill Today.

Since the implementation of the Medicare Part D program – – which AARP strongly works with – – tens of an incredible number of Medicare beneficiaries have had access to more affordable prescription medications. AARP believes we must use all equipment to restrain soaring medication prices to make sure continued affordability of this program to both Medicare beneficiaries and all taxpayers. One way to do that is certainly to further reinforce the negotiations that each plans undertake with medication manufacturers by allowing the Secretary to negotiate on behalf of Medicare beneficiaries. This issue enjoys widespread public support, as demonstrated by a recent AARP poll displaying 86 % of people – – across all political parties – – support legislation allowing the Secretary to negotiate with respect to Medicare beneficiaries.

Adjuvant therapy can be treatment given to kill remaining malignancy cells, as well as the primary therapy. Research suggest adjuvant therapy may increase the chances of long-term survival. The study, that was led by Dr. Mousumi Banerjee of the University of Michigan College of Public Health, found that among women whose cancer had become or pass on regional in nature, whites were nearly five times more likely to take tamoxifen, a widely-utilized adjuvant cancer therapy medicine, and more than three instances more likely to possess adjuvant chemotherapy. White and African American women with malignancy that had not spread received tamoxifen and chemotherapy at equal rates. Related StoriesOvarian cancer patients with a brief history of oral contraceptive use have better outcomesNew results reveal association between colorectal cancer and melanoma medication treatmentViralytics enters into medical trial collaboration contract with MSDThere was no factor in the amounts of white and African American women who received breasts conservation medical procedures versus mastectomy.However, women with early stage breasts cancer who were covered by government health insurance were less inclined to have combination breasts conserving cancer medical procedures and radiation, and much more likely to have mastectomy without radiation than individuals enrolled in non-governmental plans, or private plans.Adjuvant therapy can be treatment given to kill remaining malignancy cells, as well as the primary therapy. Research suggest adjuvant therapy may increase the chances of long-term survival. The study, that was led by Dr. Mousumi Banerjee of the University of Michigan College of Public Health, found that among women whose cancer had become or pass on regional in nature, whites were nearly five times more likely to take tamoxifen, a widely-utilized adjuvant cancer therapy medicine, and more than three instances more likely to possess adjuvant chemotherapy. White and African American women with malignancy that had not spread received tamoxifen and chemotherapy at equal rates. Related StoriesOvarian cancer patients with a brief history of oral contraceptive use have better outcomesNew results reveal association between colorectal cancer and melanoma medication treatmentViralytics enters into medical trial collaboration contract with MSDThere was no factor in the amounts of white and African American women who received breasts conservation medical procedures versus mastectomy.However, women with early stage breasts cancer who were covered by government health insurance were less inclined to have combination breasts conserving cancer medical procedures and radiation, and much more likely to have mastectomy without radiation than individuals enrolled in non-governmental plans, or private plans.